The Enterprise Value as of November 2025 (TTM) for Caplin Point Laboratories Limited (CAPPL.BO) is 107.63B

According to Caplin Point Laboratories Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 107.63B. This represents a change of 142.11% compared to the average of 44.46B of the last 4 quarters.

Caplin Point Laboratories Limited (CAPPL.BO) Historical Enterprise Value (quarterly & annually)

How has CAPPL.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Caplin Point Laboratories Limited over the last ten years is 91.10B. The current 107.63B Enterprise Value has changed 11.72% with respect to the historical average. Over the past ten years (40 quarters), CAPPL.BO's Enterprise Value was at its highest in in the March 2023 quarter at 90.83B. The Enterprise Value was at its lowest in in the December 2022 quarter at 0.

Caplin Point Laboratories Limited (CAPPL.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Caplin Point Laboratories Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Caplin Point Laboratories Limited (CAPPL.BO) Average Enterprise Value

How has CAPPL.BO Enterprise Value performed in the past?

The current Enterprise Value of Caplin Point Laboratories Limited (CAPPL.BO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Caplin Point Laboratories Limited (CAPPL.BO) Enterprise Value vs. Peers

How is CAPPL.BO’s Enterprise Value compared to its peers?

Caplin Point Laboratories Limited’s Enterprise Value is less than Glenmark Life Sciences Limited (128.77B), less than Glenmark Life Sciences Limited (128.77B), greater than Novartis India Limited (13.20B), greater than Lincoln Pharmaceuticals Limited (12.73B), greater than Bafna Pharmaceuticals Limited (393.64M), greater than Vivimed Labs Ltd. (4.17B), greater than Ortin Laboratories Limited (159.91M), greater than Ind-Swift Limited (8.90B), greater than Ind-Swift Limited (8.90B), greater than Parenteral Drugs (India) Ltd. (1.17B),

Build a custom stock screener for Caplin Point Laboratories Limited (CAPPL.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Caplin Point Laboratories Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Caplin Point Laboratories Limited (CAPPL.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Caplin Point Laboratories Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.